|
Volumn 44, Issue 2, 2005, Pages 121-124
|
How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRANSFERASE;
CIPROFLOXACIN;
ETHAMBUTOL;
ISONIAZID;
PYRAZINAMIDE;
RIFAMPICIN;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
ADOLESCENT;
ADULT;
AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
CHILD;
CLINICAL FEATURE;
DOSE TIME EFFECT RELATION;
FEMALE;
FOLLOW UP;
HUMAN;
INDIA;
KAPLAN MEIER METHOD;
LIVER TOXICITY;
LUPUS VULGARIS;
MAJOR CLINICAL STUDY;
MALE;
MYCOBACTERIUM TUBERCULOSIS;
OUTPATIENT CARE;
RETROSPECTIVE STUDY;
SHORT COURSE THERAPY;
SKIN BIOPSY;
SKIN DEFECT;
SKIN INFLAMMATION;
SKIN TUBERCULOSIS;
SURVIVAL;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TUBERCULIN TEST;
ADOLESCENT;
ADULT;
AGED;
ANTITUBERCULAR AGENTS;
CHILD;
CHILD, PRESCHOOL;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
TUBERCULOSIS, CUTANEOUS;
|
EID: 14544288323
PISSN: 00119059
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-4632.2005.02063.x Document Type: Article |
Times cited : (63)
|
References (6)
|